drugset / Trial / NCT07254286
Food Effect Study in Healthy Volunteers
RandomizedParallel-groupOpen-labelTreatment
Summary
A phase 1 open-label, randomized, crossover food effect and formulation assessment for icovamenib capsule in healthy volunteers.
Timeline
- Start
- 2025-09-11
- Primary completion
- 2026-01-14
- Completion
- 2026-01-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | icovamenib | Small molecule | 100 mg | — |
Indications
No indication recorded.